Dr. Mullen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 SW Ramsey Ave
Grants Pass, OR 97527Phone+1 541-472-7040
Education & Training
University of WashingtonResidency, Radiation Oncology, 2013 - 2017
Tufts University/Hallmark Health SystemInternship, Transitional Year, 2012 - 2013- Clemson University Calhoun Honors CollegeBS, Biochemistry, 1999 - 2013
Medical University of South CarolinaClass of 2012
Certifications & Licensure
OR State Medical License 2017 - 2025
WA State Medical License 2013 - 2018
MA State Medical License 2012 - 2013- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 110 citationsDisruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response.Stefka D. Spassieva, Thomas D. Mullen, Danyelle M. Townsend, Lina M. Obeid
The Biochemical Journal. 2009-12-01 - 376 citationsCeramide synthases at the centre of sphingolipid metabolism and biologyThomas D. Mullen, Yusuf A. Hannun, Lina M. Obeid
The Biochemical Journal. 2012-02-01 - 65 citationsCeramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells.Junfei Jin, Qi Hou, Thomas D. Mullen, Youssef H. Zeidan, Jacek Bielawski
The Journal of Biological Chemistry. 2008-09-26
Grant Support
- Ceramide Synthases Cers5 And Cers6 Regulate Pathways Of Programmed Cell DeathNational Institute Of Environmental Health Sciences2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
